Myopia in Children - Teraju Pharma
post-template-default,single,single-post,postid-117,single-format-standard,bridge-core-2.4.4,ajax_fade,page_not_loaded,,qode-title-hidden,qode_grid_1300,side_area_uncovered_from_content,qode-child-theme-ver-1.0.0,qode-theme-ver-22.9,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-6.3.0,vc_responsive

Myopia in Children


Myopia (or short-sightedness) is caused by an eye that grows too long, resulting in blurred images of distant objects. Secondly, although myopia was described as genetic, the prevalence of myopia in the developed countries of East and Southeast Asia had increased from about 10-30% to 80-90% in young adults. The myopia epidemic in Asia is evident because the prevalence of high myopia among young adults is higher among Asian (6.8%–21.6%) compared with non-Asian populations (2.0%–2.3%). High myopia is linked to pathologic myopia (PM), which may cause irreversible visual impairment (VI).

It is a very common condition. Usually myopia begins to develop in teenage years and it may get worse over the following few years.

Studies showed that aolw dose of atropine can prevent progression of myopia by 70%-80%, without any significant side effects. With the preservative free formulations, it will add safety profile to your child’s eye sight.